In vitro and in vivo evaluation of L-lactide/ε-caprolactone copolymer scaffold to support myoblast growth and differentiation

Biotechnology Progress

Volumn 29, Issue 1, 2013, Pages 197-205

  Bandyopadhyay, Balaji ^a   Shah, Viru ^a   Soram, Memtombi ^a   Viswanathan, Chandra ^a   Ghosh, Deepa ^a  

^a RELIANCE LIFE SCIENCES PVT LTD   (India)

Author keywords

Biocompatibility; Biodegradation; Muscle; Myoblasts; Scaffold

Indexed keywords

BIODEGRADABLE SCAFFOLD; CAPROLACTONE; COPOLYMER SCAFFOLDS; DEGRADATION STUDY; IN-VITRO; IN-VIVO; L-LACTIDE; MOLECULAR ANALYSIS; MULTINUCLEATED MYOTUBES; MYOBLASTS; MYOFIBERS; MYOSIN HEAVY CHAIN; MYOTUBES; PARTICULATE LEACHING; PHASE INVERSION; SATELLITE CELLS; SKELETAL MUSCLE; TISSUE DEFECTS;

BIOCOMPATIBILITY; BIODEGRADATION; COPOLYMERS; LEACHING; MICROBIOLOGY; MUSCLE; NEURONS; PROTEINS; SCAFFOLDS;

SCAFFOLDS (BIOLOGY);

CAPROLACTONE; DILACTIDE; DIOXANE DERIVATIVE; HEXANOIC ACID DERIVATIVE; LACTONE; POLYMER;

ANIMAL; ARTICLE; CELL DIFFERENTIATION; CHEMISTRY; CULTURE MEDIUM; CULTURE TECHNIQUE; CYTOLOGY; HUMAN; METABOLISM; MOUSE; MYOBLAST; RAT; SCID MOUSE; TISSUE ENGINEERING; WISTAR RAT;

ANIMALS; CAPROATES; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CULTURE MEDIA; DIOXANES; HUMANS; LACTONES; MICE; MICE, SCID; MYOBLASTS; POLYMERS; RATS; RATS, WISTAR; TISSUE ENGINEERING;

MUS;

EID: 84873304756     PISSN: 87567938     EISSN: 15206033     Source Type: Journal    
DOI: 10.1002/btpr.1665     Document Type: Article

References (32)

1. Vilquin JT. Myoblast transplantation: clinical trials and perspectives. Acta Myol. 2005; 24: 119-1127.
2. Alsberg E, Hill EE, Mooney DJ. Craniofacial tissue engineering. Crit Rev Oral Biol Med. 2001; 12: 64-75.
3. Skuk D, Tremblay JP. Intramuscular cell transplantation as a potential treatment of myopathies: clinical and preclinical relevant data. Expert Opin Biol Ther. 2011; 11: 359-374.
4. Bach AD, Beier JP, Stern-Staeter J, Horch RE. Skeletal muscle tissue engineering. J Cell Mol Med. 2004; 8: 413-422.
5. Brady MA, Lewis MP, Mudera V. Synergy between myogenic and non-myogenic cells in a 3D tissue-engineered craniofacial skeletal muscle construct. J Tissue Eng Regen Med. 2008; 2: 408-417.
6. Kroehne V, Heschel I, Schügner F, Lasrich D, Bartsch JW, Jockusch H. Use of a novel collagen matrix with oriented pore structure for muscle cell differentiation in cell culture and in grafts. J Cell Mol Med. 2008; 12: 1640-1648.
7. Huang YC, Dennis RG, Larkin L, Baar K. Rapid formation of functional muscle in vitro using fibrin gels. J Appl Physiol. 2004; 98: 706-713.
8. Kim KS, Lee JH, Ahn HH, Lee JY, Khang G, Lee HB, Kim MS. The osteogenic differentiation of rat muscle-derived stem cells in vivo within in situ-forming chitosan scaffolds. Biomaterials. 2008; 29: 4420-4428.
9. Orive G, Hernández RM, Gascón AR, Igartua M, Pedraz JL. Development and optimisation of alginate-PMCG-alginate microcapsules for cell immobilization. Int J Pharm. 2003; 259: 57-68.
10. Li Y, Song J, Yang P, Zou R, Fan X, Zhao Z. Establishment of a three-dimensional culture and mechanical loading system for skeletal myoblasts. Cell Biol Int. 2008; 33: 192-198.
11. Papenburg BJ, Liu J, Higuera GA, Barradas AM, de Boer J, van Blitterswijk CA, Wessling M, Stamatialis D. Development and analysis of multi-layer scaffolds for tissue engineering. Biomaterials. 2009; 30: 6228-6239.
12. Jun I, Jeong S, Shin H. The stimulation of myoblast differentiation by electrically conductive sub-micron fibers. Biomaterials. 2009; 30: 2038-2047.
13. Riboldi SA, Sampaolesi M, Neuenschwander P, Cossu G, and Montero S. Electrospun degradable polyesterurethane membranes: potential scaffolds for skeletal muscle tissue engineering. Biomaterials. 2005; 26: 4606-4615.
14. Engler AJ, Griffin MA, Sen S, Bonnemann CG, Sweeny HL, Discher DE. Myotubes differentiate optimally on substrate with tissue-like stiffness: pathological implications for soft of stiff microenvironments. J Cell Biol. 2004; 166: 877-887.
15. Inoguchi H, Kwon IK, Inoue E, Takamizawa K, Maehara Y, Matsuda T. Mechanical responses of a compliant electrospun poly(L-lactide-co-epsilon-caprolactone) small-diameter vascular graft. Biomaterials. 2006; 27: 1470-1478.
16. Bölgen N, Menceloǧlu YZ, Acatay K, Vargel I, Pişkin E. In vitro and in vivo degradation of non-woven materials made of poly(ε-caprolactone) nanofibers prepared by electrospinning under different conditions. J Biomater Sci Polym Ed. 2005; 16: 1537-1555.
17. Holy CE, Cheng C, Davies JE, Shoichet MS. Optimizing the sterilization of PLGA scaffolds for use in tissue engineering. Biomaterials. 2001; 22: 25-31.
18. Holy CE, Shoichet MS, Davies JE. Engineering three-dimensional bone tissue in vitro using biodegradable scaffolds investigating initial cell-seeding density and culture period. J Biomed Mater Res. 2000; 51: 376-382.
19. Thaloor D, Miller KJ, Gephart J, Mitchell OP, and Pavlath GK. Systemic administration of the NFkB inhibitor curcumin stimulates muscle regeneration after traumatic injury. Am J Physiol Cell Physiol. 1999; 277: 320-329.
20. Molinari BL, Tasat DR, Palmieri MA, O'Connor SE, Cabrini RL. Cell-based quantitative evaluation of the MTT assay. Anal Quant Cytol Histol. 2003; 209: 254-262.
21. Bandyopadhyay B, Fan J, Guan S, Li Y, Chen M, Woodley DT. A traffic control role for TGFβ3: orchestrating dermal and epidermal cell motility during wound healing. J Cell Biol. 2006: 1093-1105.
22. Huang YC, Dennis RG, Larkin L, Baar K. Rapid formation of functional muscle in vitro using fibrin gels. J Appl Physiol. 2004; 98: 706-713.
23. Ameer GA, Mahmood TA, Langer R. A biodegradable composite scaffold for cell transplantation. J Orthop Res. 2002; 20: 16-19.
24. Woodfield TB, Bezemer JM, Pieper JS, van Blitterswijk CA, Riesle J. Scaffolds for tissue engineering of cartilage. Crit Rev Eukaryot Gene Expr. 2002; 12: 209-236.
25. Kim SH, Kwon JH, Chung MS, Chung E, Jung Y, Kim SH, Kim YH. Fabrication of a new tubular fibrous PLC scaffold for vascular tissue engineering. J Biomat Sci. 2006; 17: 1359-1374.
26. Jeong SI, Kim SH, Kim YH, Jung Y, Kwon JH, Kim BS. Manufacture of elastic biodegradable PLC scaffolds for mechano-active vascular tissue engineering. J Biomater Sci Polym Ed. 2004; 15: 645-660.
27. Woodward SC, Brewer PS, Moatamed F, Schindler A, Pitt CG. The intracellular degradation of poly(ε-caprolactone). J Biomed Mater Res. 1985; 19: 437-444.
28. Gunatillake PA, Adhikari R. Biodegradable synthetic polymers for tissue engineering. E Cells Mater. 2003; 5: 1-16.
29. Bramfeldt H, Sarazin P, Vermette P. Characterization, degradation, and mechanical strength of poly(D, L-lactide-co-epsilon-caprolactone)-poly(ethylene glycol)-poly(D, L-lactide-co-epsilon-caprolactone). J Biomed Mater Res A. 2007; 83: 503-511.
30. Beier JP, Klumpp D, Rudisile M, Dersch R, Wendorff JH, Bleiziffer O. Collagen matrices from sponge to nano: new perspectives for tissue engineering of skeletal muscle. BMC Biotechnol. 2009; 15: 34.
31. Stern-Straeter J, Bach AD, Stangenberg L, Foerster VT, Horch RE, Stark GB, Beier JP. Impact of electrical stimulation on three-dimensional myoblast cultures-a real-time RT-PCR study. J Cell Mol Med. 2005; 9: 883-892.
32. Sakiyama K, Abe S, Tamatsu Y, Ide Y. Effects of stretching stress on the muscle contraction proteins of skeletal muscle myoblasts. Biomed Res. 2005; 26: 61-68.